According to www.techsciresearch.com latest Report- Global oncology drugs market is projected to grow at a brisk rate over the forecast period owing to widespread prevalence of cancer, globally. Report URL- https://www.techsciresearch.com/report/oncology-drugs-market/4689.html

1. MARKET INTELLIGENCE . CONSULTING
www.techsciresearch.com
2015 – 2025
GLOBAL ONCOLOGY DRUGS MARKET
FORECAST & OPPORTUNITIES

2. 2
Scope of Report
Product of Interest (POI): Oncology Drugs
Review Period
2015 – 2018
Base Year
2019
Estimated Year
2020
Forecast Period
2021 – 2025
Year Range
REGION
• Asia-Pacific
• Europe
• North America
• South America
• Middle East & Africa
Global oncology drugs market is projected to grow at a brisk rate over the forecast period owing to
widespread prevalence of cancer, globally. Various other related factors which are contributing to the
growth of oncology drugs market include rise in geriatric population worldwide, increase in global
healthcare expenditure, rising number of product approvals by regulatory bodies and growing R&D
activities for the development of new cancer drugs. Furthermore, emergence of biosimilar products for
cancer treatment, increasing collaborations between pharmaceutical companies and development of
pipeline oncology products are providing opportunities for various oncology drug manufacturers.
Market Segmentation
THERAPY
• Chemotherapy
• Targeted Therapy
• Immunotherapy
(Biologic Therapy)
• Hormonal Therapy
• Others
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Government Hospitals
DISTRIBUTION
CHANNEL
CANCER TYPE
• Lung Cancer
• Stomach Cancer
• Colorectal Cancer
• Breast Cancer
• Prostate Cancer
• Liver Cancer
• Esophagus Cancer
• Cervical Cancer
• Kidney Cancer
• Bladder Cancer
• Others
DRUG TYPE
• Cytotoxic Drugs
• Targeted Drugs
• Hormonal Drugs
GENDER
• Male
• Female
DRUG THERAPY
• Adjuvant
• Neoadjuvant
• Concurrent
ROUTE OF ADMINISTRATION
• Oral
• Intravenous
• Subcutaneous
• Others

3. 3
Table of Contents
S. No. Contents Page No.
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Oncology Drugs Market
4. Executive Summary
5. Voice of Customer
6. Global Oncology Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Type (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs)
6.2.2.
By Therapy (Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal
Therapy, Others)
6.2.3. By Drug Therapy (Adjuvant, Neoadjuvant and Concurrent)
6.2.4. By Route of Administration (Oral, Intravenous, Subcutaneous, Others)
6.2.5. By Gender (Male, Female)
6.2.6.
By Cancer Type (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate
Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer,
Others)
6.2.7.
By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies,
Government Hospitals)
6.2.8. By Company (2019)
6.2.9. By Region (Asia-Pacific, Europe, North America, South America and Middle East &
Africa)
6.3. Product Market Map

4. 4
Table of Contents
S. No. Contents Page No.
7. Asia-Pacific Oncology Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Type
7.2.2. By Therapy
7.2.3. By Drug Therapy
7.2.4. By Route of Administration
7.2.5. By Gender
7.2.6. By Cancer Type
7.2.7. By Country (China, India, Australia, Japan, South Korea)
7.3. Asia-Pacific: Country Analysis
7.3.1. China Oncology Drugs Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drug Type
7.3.1.2.2. By Therapy
7.3.1.2.3. By Drug Therapy
7.3.1.2.4. By Route of Administration
7.3.1.2.5. By Gender
7.3.1.2.6. By Cancer Type

5. 5
Table of Contents
S. No. Contents Page No.
7.3.2. India Oncology Drugs Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drug Type
7.3.2.2.2. By Therapy
7.3.2.2.3. By Drug Therapy
7.3.2.2.4 By Route of Administration
7.3.2.2.5. By Gender
7.3.2.2.6. By Cancer Type
7.3.3. Australia Oncology Drugs Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drug Type
7.3.3.2.2. By Therapy
7.3.3.2.3. By Drug Therapy
7.3.3.2.4. By Route of Administration
7.3.3.2.5. By Gender
7.3.3.2.6. By Cancer Type

6. 6
Table of Contents
S. No. Contents Page No.
7.3.4. Japan Oncology Drugs Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Drug Type
7.3.4.2.2. By Therapy
7.3.4.2.3. By Drug Therapy
7.3.4.2.4 By Route of Administration
7.3.4.2.5. By Gender
7.3.4.2.6. By Cancer Type
7.3.5. Australia Oncology Drugs Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Drug Type
7.3.5.2.2. By Therapy
7.3.5.2.3. By Drug Therapy
7.3.5.2.4. By Route of Administration
7.3.5.2.5. By Gender
7.3.5.2.6. By Cancer Type

7. 7
Table of Contents
S. No. Contents Page No.
8. Europe Oncology Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Type
8.2.2. By Therapy
8.2.3. By Drug Therapy
8.2.4. By Route of Administration
8.2.5. By Gender
8.2.6. By Cancer Type
8.2.7. By Country (France, Germany, United Kingdom, Italy, Spain)
8.3. Asia-Pacific: Country Analysis
8.3.1. France Oncology Drugs Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drug Type
8.3.1.2.2. By Therapy
8.3.1.2.3. By Drug Therapy
8.3.1.2.4. By Route of Administration
8.3.1.2.5. By Gender
8.3.1.2.6. By Cancer Type

8. 8
Table of Contents
S. No. Contents Page No.
8.3.2. Germany Oncology Drugs Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drug Type
8.3.2.2.2. By Therapy
8.3.2.2.3. By Drug Therapy
8.3.2.2.4 By Route of Administration
8.3.2.2.5. By Gender
8.3.2.2.6. By Cancer Type
8.3.3. United Kingdom Oncology Drugs Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drug Type
8.3.3.2.2. By Therapy
8.3.3.2.3. By Drug Therapy
8.3.3.2.4. By Route of Administration
8.3.3.2.5. By Gender
8.3.3.2.6. By Cancer Type

9. 9
Table of Contents
S. No. Contents Page No.
8.3.4. Italy Oncology Drugs Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Drug Type
8.3.4.2.2. By Therapy
8.3.4.2.3. By Drug Therapy
8.3.4.2.4 By Route of Administration
8.3.4.2.5. By Gender
8.3.4.2.6. By Cancer Type
8.3.5. Spain Oncology Drugs Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Drug Type
8.3.5.2.2. By Therapy
8.3.5.2.3. By Drug Therapy
8.3.5.2.4. By Route of Administration
8.3.5.2.5. By Gender
8.3.5.2.6. By Cancer Type

10. 10
Table of Contents
S. No. Contents Page No.
9. North America Oncology Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Type
9.2.2. By Therapy
9.2.3. By Drug Therapy
9.2.4. By Route of Administration
9.2.5. By Gender
9.2.6. By Cancer Type
9.2.7. By Country (United States, Mexico, Canada)
9.3. North America: Country Analysis
9.3.1. United States Oncology Drugs Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drug Type
9.3.1.2.2. By Therapy
9.3.1.2.3. By Drug Therapy
9.3.1.2.4. By Route of Administration

11. 11
Table of Contents
S. No. Contents Page No.
9.3.1.2.5. By Gender
9.3.1.2.6. By Cancer Type
9.3.2. Mexico Oncology Drugs Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drug Type
9.3.2.2.2. By Therapy
9.3.2.2.3. By Drug Therapy
9.3.2.2.4 By Route of Administration
9.3.2.2.5. By Gender
9.3.2.2.6. By Cancer Type
9.3.3. Canada Oncology Drugs Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drug Type
9.3.3.2.2. By Therapy
9.3.3.2.3. By Drug Therapy
9.3.3.2.4. By Route of Administration
9.3.3.2.5. By Gender
9.3.3.2.6. By Cancer Type

12. 12
Table of Contents
S. No. Contents Page No.
10. South America Oncology Drugs Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Drug Type
10.2.2. By Therapy
10.2.3. By Drug Therapy
10.2.4. By Route of Administration
10.2.5. By Gender
10.2.6. By Cancer Type
10.2.7. By Country (Brazil, Argentina, Colombia)
10.3. South America: Country Analysis
10.3.1. Brazil Oncology Drugs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Drug Type
10.3.1.2.2. By Therapy
10.3.1.2.3. By Drug Therapy
10.3.1.2.4. By Route of Administration

13. 13
Table of Contents
S. No. Contents Page No.
10.3.1.2.5. By Gender
10.3.1.2.6. By Cancer Type
10.3.2. Argentina Oncology Drugs Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Drug Type
10.3.2.2.2. By Therapy
10.3.2.2.3. By Drug Therapy
10.3.2.2.4 By Route of Administration
10.3.2.2.5. By Gender
10.3.2.2.6. By Cancer Type
10.3.3. Colombia Oncology Drugs Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Drug Type
10.3.3.2.2. By Therapy
10.3.3.2.3. By Drug Therapy
10.3.3.2.4. By Route of Administration
10.3.3.2.5. By Gender
10.3.3.2.6. By Cancer Type

14. 14
Table of Contents
S. No. Contents Page No.
11. Middle East and Africa Oncology Drugs Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Drug Type
11.2.2. By Therapy
11.2.3. By Drug Therapy
11.2.4. By Route of Administration
11.2.5. By Gender
11.2.6. By Cancer Type
11.2.7. By Country (South Africa, Saudi Arabia, UAE, Kuwait)
11.3. Middle East and Africa: Country Analysis
11.3.1. South Africa Oncology Drugs Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Drug Type
11.3.1.2.2. By Therapy
11.3.1.2.3. By Drug Therapy
11.3.1.2.4. By Route of Administration

15. 15
Table of Contents
S. No. Contents Page No.
11.3.1.2.5. By Gender
11.3.1.2.6. By Cancer Type
11.3.2. Saudi Arabia Oncology Drugs Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Drug Type
11.3.2.2.2. By Therapy
11.3.2.2.3. By Drug Therapy
11.3.2.2.4 By Route of Administration
11.3.2.2.5. By Gender
11.3.2.2.6. By Cancer Type
11.3.3. UAE Oncology Drugs Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Drug Type
11.3.3.2.2. By Therapy
11.3.3.2.3. By Drug Therapy
11.3.3.2.4. By Route of Administration
11.3.3.2.5. By Gender
11.3.3.2.6. By Cancer Type

16. 16
Table of Contents
S. No. Contents Page No.
11.3.4. Kuwait Oncology Drugs Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Drug Type
11.3.4.2.2. By Therapy
11.3.4.2.3. By Drug Therapy
11.3.4.2.4. By Route of Administration
11.3.4.2.5. By Gender
11.3.4.2.6. By Cancer Type
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
15. Strategic Recommendations
16. About Us & Disclaimer

17. RESEARCHMETHODOLOGY

18. 18
Research Methodology
 Identifying Key Opinion
Leaders
 Questionnaire Design
 In-depth Interviews
Data
Collection
Developing List
of Respondents
Formulating
Questionnaire
Market
Profiling
Data
Validation
Data
Analysis
In-depth secondary
research was conducted to
determine top players in
the global oncology drugs
market, overall market size
and segmental market size.
In order to conduct
industry experts’
interviews, TechSci
formulated a detailed
discussion guide.
List of industry
players and industry
specialists was
developed.
TechSci conducted
interviews with
industry experts and
industry players for
data collection and
verification.
Data obtained as a
result of primary
and secondary
research was
validated through
rigorous
triangulation.
The data was scrutinized
using MS-Excel, statistical
tools and internal
proprietary database to
obtain qualitative and
quantitative insights about
the global oncology drugs
market.
Data
Collection
Data Filter
& Analysis
Research &
Intelligence
Actionable
Insights
Business
Solution
Primary Research Desk Research Company Analysis
 Recent Developments
 Market Changing
Aspects/Dynamics
 Government Policies
 Conclusion
 Market Participants
 Key Strengths
 LinkedIn
 TechSci Internal
Database
 Factiva
 Hoovers
Paid Sources
 Company Websites
 Company Annual
Reports
 White Paper Study
 Financial Reports
 Investor
Presentations
 Regulatory Body
 Associations, etc.
Secondary
Research
Primary Research

19. 19
Research Methodology
Baseline Methodology
Our dedicated team of industry experts has monitored and analyzed various aspects of the global oncology drugs market. The team has
market, while considering the major influencing factors such as growing R&D activities for the development of new cancer drugs. The
enable our clients to take better decisions while planning their strategy to achieve sustainability in the global oncology drugs market.
Methodology Followed for Calculation of Market Size:
• Market Size by Value: Market size, in terms of value, for the year 2019 was calculated based on information collected through
exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as oncology drugs
users, industry experts, and other industry participants.
• The team interviewed more than 15 – 20 oncology drugs companies, 100 – 120 end-users, and 15 – 20 industry experts and other
drugs market to obtain the overall market size from 2015 to 2019, which was validated by the Delphi technique. Taking standard
averaged out, to arrive at the market size data during 2015-2019.

20. 20
Research Methodology
• Respondents were asked about the current and future market growth rates, market shares by drug type, by therapy, by drug therapy, by route of administration, by gender, by cancer
type, by distribution channel, by company and by region. Removing the outlier responses, the geometric mean of growth estimates and provider wise revenue shares generated
across various segments were considered, to arrive at the final revenue shares. Revenue shares generated across various segments were further triangulated from other
stakeholders.
Methodology Followed for Calculation of Market Shares:
• Market share by drug type, by therapy, by drug therapy, by route of administration, by gender, by cancer type, by distribution channel, by company and by region were calculated
based on the responses received through primary surveys with industry experts, in which the respondents were asked about the market shares or revenue generated from various
segments of oncology drugs markets. The final shares were calculated by taking the geometric mean of the responses gathered from key opinion leaders after eliminating the
outliers.
Methodology Followed for Forecasting:
• TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in SPSS/Tableau Software.
• Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast global oncology drugs market, TechSci Research used
various forecast techniques such as:
 Moving Average
 Time Series Analysis
 Regression Analysis
 Econometric and Judgmental Analysis

21. 21
Research Methodology
TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used the impact analysis during
short, medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that the figures compiled are only for the organized market
including market share data. The currency used in the report is the United States Dollar (USD), with the market size indicated in USD million.
Partial List of Companies Interviewed Key Secondary Sources
• Abbott Laboratories
• AbbVie Inc
• Roche Holding AG
• Novartis International AG
• Johnson & Johnson
• Bristol-Myers Squibb Company
• Celgene Corporation
• Merck & Co., Inc
• Pfizer Inc.
• Eli Lilly
• AstraZeneca PLC
• Takeda Pharmaceutical
• Amgen
• Astellas Pharma
• Sanofi SA
• Eisai
• Thermo Fisher Scientific
• Astex Pharmaceutical
• Daiichi Sankyo
• Teva Pharmaceutica
 World Bank
 TechSci Research Proprietary Database & Knowledge Repository
 Company Annual Reports
 Industry Magazines
 Industry Reports
 News Dailies
 Credible Paid Databases

22. 22
INDUSTRY BRIEF
According to TechSci Research report, “Global Oncology Drugs Market By Drug Type, By Therapy, By Drug Therapy, By Route of Administration, By Gender, By Cancer Type, By Distribution
Channel, By Region, Competition, Forecast & Opportunities, 2025”, the global oncology drug market is anticipated to continue following its growth trajectory through 2025 due to rising prevalence of
cancer worldwide, increasing geriatric population and growing healthcare expenditure. Other key drivers behind the growth of this market are increasing number drug approvals, emergence of
biosimilar products for cancer treatment, growing research & development activities for developing new cancer drugs and increasing governments' expenditure on healthcare infrastructure.
The fatal nature of cancer and low rate of success for treatments, has compelled medical practitioners to conduct new research methodologies for better and advanced treatments. Population in
various developed countries like the US are projected to become increasingly aged and show rising obesity incidence, which will drive both cancer prevalence and consequently revenue growth for
its treatments in the coming years. But apart from the factors leading to growth of oncology drugs market, there are some restrains as well. The side effects and long-term sequelae of anti-cancer
chemotherapy tend to impede the market growth. Also, adverse effects of oncology drugs and expensive treatments pose hindrance to the growth of the market, globally.
The global oncology drugs market is segmented based on drug type, therapy, drug therapy, route of administration, gender, cancer type, distribution channel and region. Based on drug type, the
market is segmented into cytotoxic drugs, targeted drugs and hormonal drugs. The targeted therapy and chemotherapy segments cumulatively hold majority share in the global oncology drugs
market. The targeted therapy kills only malignant cells and has good survival rates. However, the immunotherapy segment is expected to register the highest growth rate during the forecast period
owing to higher rates of survival and remission related to their use.
Based on cancer type, the market is segmented into lung cancer, stomach cancer, colorectal cancer, breast cancer, prostate cancer, liver cancer, esophagus cancer, cervical cancer, kidney cancer,
bladder cancer and others. The lung cancer segment holds the largest share in the global oncology drugs market due to high prevalence of the disease, globally. AbbVie Inc, Roche Holding AG,
Novartis International AG, Johnson & Johnson, Bristol-Myers Squibb Company, Celgene Corporation, Merck & Co., Inc, Pfizer Inc., Eli Lilly, AstraZeneca PLC, Takeda Pharmaceutical, Amgen,
Astellas Pharma, Sanofi SA , Eisai Inc., Abbott Laboratories, Thermo Fisher Scientific, Astex Pharmaceutical, Daiichi Sankyo and Teva Pharmaceutical are some of the leading players operating in
global oncology drugs market. Key manufacturers are trying to focus on introducing more personalized medicines to target cancer treatment and thereby enhance their market share. They are also
focusing on strategies such as mergers with research institutes and acquisition of small market players in order to grab higher market share.
“North American players hold a strong dominance in the global oncology drugs market as they have better medical treatment options available and companies out there have a significantly higher
focus on R&D activities. US and Canada register highest survival rate during the course of cancer treatment. Increasing product approvals by regulatory bodies for the treatment of various cancers is
also positively impacting the market. Altogether, the future of global oncology drugs market is bright with development of pipeline oncology products and expiry of key patents providing opportunities
for drug manufacturers.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

23. 23
SAMPLE DATA - SNAPSHOT
Global Oncology Drugs Market Size, By Value (USD Million), 2015-2025F
5.00 6.00 7.00 8.00 9.00 10.00 11.00 12.00 13.00 14.00 15.00
2015 2019 2020E 2025F
By Value (USD Million)
CAGR By Value CAGR By Value
XX% YY%
North America Oncology Drugs Market Share, By Drug Type, By Value, 2015–2025F
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
34%
34%
34%
34%
34%
34%
34%
34%
34%
34%
34%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
2015
2016
2017
2018
2019
2020E
2021F
2022F
2023F
2024F
2025F
Cytotoxic Drugs Targeted Drugs Hormonal Drugs
United States Oncology Drugs Market Share, By Route of Administration, By Value, 2015–2025F
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
2015
2016
2017
2018
2019
2020E
2021F
2022F
2023F
2024F
2025F
Oral Intravenous Subcutaneous Others

24. 24
REPORT ORDERING
License Type Price
Electronic Access - Single User License $4450
Electronic Access - Multi-User License $5450
Custom Research License $9450
Report Price
To View Sample OR Purchase Report
Report Name: GLOBAL ONCOLOGY DRUGS MARKET
FORECAST & OPPORTUNITIES
2015 – 2025

25. About Us & Disclaimer
TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in
number of areas to organizations. The company uses innovative business Modes that focus on improving productivity, while ensuring creation of high-quality
of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ Mode of a country, regional and global industry
activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the market.
Related Reports
• Global Clinical Diagnostics Market By Virus Type of Test (Lipid Panel, Metabolic Panel, Infectious Disease Testing, Others), By Virus Type
(Instruments, Reagents, Assays and Kits, Software), By Genetic Information (Infectious Disease (COVID-19, Sepsis, HIV , Others), Cardiology,
Cancer), By Region, Competition, Forecast & Opportunities, 2025
• Global Electronic Skin Patches Market By Genetic Information (Cardiovascular Monitoring, Wireless Inpatient Monitoring, Diabetes Management,
Iontophoresis Skin patches, Sweat Sensing), By Material (Silicon Based, Polymer Based and Others), By Test Type (Disposable and Reusable), By
End User (Hospitals, Ambulatory Surgical Centers and Others), By Region, Forecast & Opportunities, 2025
The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely,
accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it
considers reliable and firsthand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible
for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the
subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this
document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior
approval of TechSci Research.
TechSci Research – North America
708 Third Avenue, Manhattan,
New York, United States
Tel: +1- 646- 360- 1656
Email: sales@techsciresearch.com
www.techsciresearch.com
Disclaimer
TechSci Research – Europe
54, Old brook, Bretton,
Peterborough,
United Kingdom
Email: sales@techsciresearch.com
www.techsciresearch.com
TechSci Research – Asia-Pacific
B – 44, Sector – 57, Noida, National Capital
Region, U.P. - India
Tel: +91-120-4523900
Email: sales@techsciresearch.com
www.techsciresearch.com